Dr Steven Reisman
★★★★★

350+ Reviews

Steven Reisman MD

Seeing patients at

Nationally Recognized Cardiologist

LinkedIn Profile

Dr. Reisman, a compassionate and caring physician, provides cardiac care recognized as among the best in New York and the world. He is affiliated with the best-rated hospitals, including NYU Langone.

  • Expedited Appointments
  • Most Insurances Accepted
  • Non-Invasive Testing

Nationally Recognized Cardiologist

Dr. Steven Reisman is a nationally recognized cardiologist and the Director of the New York Cardiac Diagnostic Center. He has authored numerous publications and presented original research at the American College of Cardiology & the American Heart Association. The leading cardiovascular specialist Dr. Reisman has been featured on FOX, CNN, and the New York Post.

The patient-centered cardiovascular center in Manhattan is a highly specialized diagnostic and testing facility offering a full range of diagnostic services, high-quality expertise, and convenient daytime and evening hours.

Authority and Expertise

Dr. Reisman has received advanced training in the prevention and treatment of heart and blood vessel diseases. He has long been regarded as a paragon of authority and expertise among the country's leading cardiovascular specialists.

Dr. Reisman is one of the best cardiologists in Manhattan to see if you have heart problems because he can use the most advanced tests to diagnose the problem more accurately.

Initially, Dr. Reisman will evaluate your symptoms, consider your medical history before recommending appropriate tests to gain a definitive diagnosis. Once he has this information, he can decide if he can manage your care using medicine or other non-invasive treatments.

accolades, accreditations, and recognitions

Innovation

  • As an investigator with the Food and Drug Administration, he was instrumental in developing a new stress test for those who are unable to exercise (FDA)
  • Founding member of the American Society of Nuclear Cardiology (ASNC)
  • Multiple presentations of original research at annual scientific cardiology meetings
  • Research scientist in nuclear cardiology at Cedars – Sinai medical center
  • Media interviews on the latest developments in cardiology
  • Founder of the New York Cardiac Diagnostic Center
accolades, accreditations, and recognitions

Dr. Steven Reisman and his cardiac team at New York Cardiac Diagnostic Center are the best! The cardiologist takes a preventative view of heart health. I went for a stress test and it was anything but stressful thanks to Dr. Reisman! It really is better to prevent heart trouble than to have to deal with the consequences. This doctor is wonderful and thorough when it comes to cardiac testing and diagnosis and just knowing that everything is ok and knowing that I have a doctor who is a genuine expert in his field certainly gives me a sense of peace.

L S.

The best! Staff was amazing getting me a last minute appointment- literally within the hour: Kuddos to them. Dr. Resin an is a rare rare find. He listened Didn't rush me. Amazing advice . Amazing bedside manner, TOP NOTCH. 5plus star. Booked my follow up appointment personally with his staff. The BEst.

Lisa S.

I can’t say enough about Dr. Reisman and his staff. They are the most professional people I have ever dealt with, and the techs are A-1. They saved my life as I happened to have a dangerous condition that required open heart surgery, and I was asymptomatic. Their excellent diagnostic testing picked it up, and I had the same tests done elsewhere with normal results. I would very highly recommend New York Cardiac Diagnostic Center.

Sally V
Heart Attack and Sudden Cardiac Death Aortic Valve Surgery Women and Heart Disease Aspirin in the Prevention of Heart Disease
Phone Icon
For a Consultation call: (212) 860-0796

Cutting Edge Research

Dr. Reisman was involved in some of the most significant and exciting developments in cardiovascular medicine.

  • “In patients with a strongly positive exercise electrocardiogram does longer exercise duration mean less extensive ischemia?” Original research presented at the American College of Cardiology.
  • “The severe stress thallium-201 defect: An indicator of critical coronary stenosis.” Original research presented at the American Heart Association.
  • “Silent myocardial ischemia during treadmill exercise: Thallium scintigraphic and angiographic correlates.” Original research presented at the American College of Cardiology
  • “Asymptomatic patients with exercise thallium-201 hypoperfusion: Identification of a high-risk subset.” Original research presented at the American Heart Association.
  • “A computerized method for quantification of extent, depth and severity of defects in patients undergoing exercise planar thallium-201 Scintigraphy.” Original research presented at the Society of Nuclear Medicine.
  • “Myocardial perfusion imaging with thallium-201 in the detection and assessment of coronary artery disease.” Book chapter.
  • “Dipyridamole thallium testing: An alternative form of stress testing in patients unable to exercise.” Editorial in the scientific journal Chest.
View all publications on Google Scholar
More Publications

What Does Our Center Provide?

The New York Cardiology Diagnostic Center is a world-class facility for cardiac testing and treatment. We use cutting-edge stress tests and cardiac screenings to diagnose a variety of heart conditions, including:

Some of the tests we offer to assess and diagnose all types of cardiac ailments are as follows:

  • Cardiac Screening, such as:
    • High Blood Pressure
    • Sports Cardiology / Athletic Heart
    • Stroke
    • Sudden Cardiac Death
    • Heart Palpitations
    • Coronary Disease
  • Cardiac Testing, such as:
    • ECG / Electrocardiogram
    • Echocardiogram (echo)
    • Vascular Ultrasound
    • Electrocardiographic (ECG)
    • Endo-PAT Test
    • Stress Test
Your heart health is important, and the best form of prevention is early detection. Dr. Reisman will personally supervise your diagnostic procedure, ensuring that you receive the best cardiac care possible!

As with many diseases, early detection is the best approach and can prevent heart issues from deteriorating. It is essential to consult with your cardiac specialist to rule out the risk of a heart attack. If necessary, Dr. Reisman can refer you to a cardiac center that specializes in more sophisticated testing.

Why Visit Dr. Reisman?

The majority of patients come to Dr. Reisman with unexplained heart symptoms. If you have a family history of heart disease, you can schedule an appointment to learn more about your risk factors for heart disease. Dr. Reisman can advise you on how to protect your cardiovascular health. Choosing a highly qualified specialist is critical when dealing with something as complex as heart disease.

schedule a
Consultation call:

Call now
(212) 860-0796

Dr. Reisman was part of a group of select doctors with the Food And Drug Administration evaluating intravenous dipyridamole thallium testing prior to the approval of this technique by the FDA in patients who cannot exercise.

Dr. Reisman has presented original research findings at both the American College of Cardiology and the American Heart Association annual meetings on the following topics:

  1. Early detection of "high risk" heart disease
  2. The evaluation of patients without symptoms with underlying heart blockages including those with "silent ischemia"
  3. The prognosis of patients with blockages and the use of dipyridamole thallium testing in patients who cannot exercise to identify severe blockages
  4. Detection of severe coronary artery disease in the elderly
  5. The evaluation of heart disease in patients who cannot walk secondary to a circulatory problem

High-Quality Personalized Care

Dr. Reisman

Dr. Reisman is a firm believer in providing truly personalized cardiac diagnostic evaluations that are free of compromise. Dr. Reisman has over 30 years of experience in the cardiovascular field and can offer unparalleled expertise, high-quality care, and cutting-edge technology. He is one of the top specialists, providing patients with the most comprehensive plan to reduce their risk of heart disease. Each of your visits is individually planned and meticulously executed.

The Latest Diagnostic Technology

Dr. Reisman has streamlined the way you are diagnosed through innovative research and using the latest heart tests technology. Our center is equipped with the most advanced testing equipment that provides you with the most accurate cardiac diagnosis.

Our center provides in-house heart screening that enables us to detect potential diseases at their earliest stage, making it possible to manage or even prevent severe heart disease. Using the latest in imaging techniques, diagnostic heart tests, and precise analysis, you can make better decisions regarding your care and treatment.

Cardiovascular Diagnostic Technology

Why Should You See a Cardiology Doctor Instead of a Primary Care Physician If You Have Heart Problems?

The quality of cardiovascular care is better with the specialist than internal medicine or primary care doctors. Cardiac doctors are more likely than internists and family practitioners to perform on-site testing, such as a stress test, Holter monitoring, and echocardiography.

According to the study “Effect of cardiologist care …” published on PUBMED: “Compared with non-specialist care, cardiologist care improves patient adherence to evidence-based medications and might thus favourably affect mortality and readmission”

According to the study “Knowledge, Patterns of Care, and Outcomes of Care for Generalists and Specialists” published on PUBMED: "Patients cared for by cardiologists had a significantly lower adjusted mortality and hospital length of stay."

Credentials and Achievements

Dr. Reisman is dedicated to providing the best cardiac care possible, holding a number of academic appointments as well as clinical and research fellowships. He has published numerous studies and is an innovator who is active in advancing cardiology.

Memberships and Professional Societies

  1. American College of Cardiology – Member
  2. American Heart Association – Member
  3. American Heart Association – Member Radiology Council
  4. American Society of Nuclear Cardiology- Founding Member

Licensures & Certifications

  1. New York State License
  2. American Board of Internal Medicine- Board Certified
  3. Subspecialty Cardiovascular Disease- Board Eligible
  4. Certification Board of Nuclear Cardiology-Board Certified

Education

  1. BA: Liberal Arts/Pre-Medicine, Yeshiva University, New York, NY
  2. MD: Medicine, Wayne State University School of Medicine, Detroit, MI

Internships & Residencies

  1. Internship in Internal Medicine, Wayne State University Affiliated Hospitals, Hutzel Hospital, Detroit, Michigan
  2. Residency in Internal Medicine, Cornell Cooperative Program, North Shore University Hospital, Manhasset, New York

Clinical & Research Fellowships

  1. Cardiology Fellowship, Westchester County Medical Center, New York Medical College, Valhalla, New York
  2. Research Fellow in Nuclear Cardiology, Division of Cardiology,Departments of Medicine & Nuclear Cardiology, Cedars-Sinai Medical Center, Los Angeles, California

Academic Appointments

  1. Assistant Professor of Medicine, University of California, Irvine
  2. Research Scientist, Cedars-Sinai Medical Center, Los Angeles, California
  3. Assistant Professor of Medicine, State University of New York, Downstate Medical Center

Hospital Appointments

  1. Co-Director, Nuclear Cardiology, Long Beach, California; Director, Nuclear Cardiac Stress Laboratory. Attending Cardiologist –Long Beach Veterans Administration Medical Center
  2. Director, Nuclear Cardiology, Brooklyn, New York, The Long Island College Hospital

Other Professional Positions & Visiting Appointments

  1. Research Scientist- Nuclear Cardiology, Cedars Sinai Medical Center, Los Angeles, California
  2. Director, New York Cardiac Diagnostic Center, New York, New York

Research Studies

  1. Principal Investigator, Hemodynamic, Respiratory, Metabolic and Clinical Effects of Minoxidil in Chronic, Heart Failure $28,500.
  2. Principal Investigator, Efficacy and Safety of Nisoldipine and Placebo in the Treatment of Stable Angina Pectoris.

Publications: Abstracts

  1. Reisman S, Berman D, Maddahi J, Kimchi A, Murphy F, Rozanski A, Garcia E, Swan HJC: The severe stress thallium-201 defect in patients with and without myocardial infarction: An indicator of critical coronary stenosis. Clin Nucl Med 7(9S): p 32, 1982.
  2. Reisman D, Maddahi J, Murphy F, Kimchi A, Rozanski A, Swan HJC, Berman D: Does longer exercise duration signify less extensive ischemia in patients with a strongly positive exercise electrocardiogram? Assessment by thallium-201 scintigraphy. Clin Nucl Med 7 (9S): p 33. 1982.
  3. Murphy FL, Maddahi J, Bateman T, Becerra A, Steuer M, Reisman S, Kimchi A, Rozanski A, Garcia E, Swan HJC, Berman D: Effect of submaximal exercise heart rate on the results of quantitative thallium-201 stress testing. Clin Nucl Med 7 (9S): p 33, 1982.
  4. Murphy FL, Maddahi J, Becerra A, Steuer M, Garcia E, Kimchi A, Reisman S, Rozanski A, Swan HJC, Berman DS: Improved evaluation of coronary artery disease by addition of a third view to Tl-201 planar imaging.  Clin Nucl Med 7(9S):  p 48, 1982.
  5. Kimchi A, Rozanski A, Fletcher C, Maddahi J, Reisman S, Murphy F, Swan HJC, Berman D:  Improvement of myocardial asynergy during exercise:  Assessment with exercise equilibrium radionuclide ventriculography.  Clin Nucl Med 7(9S): p. 34, 1982.
  6. Kimchi A, Berman D, Rozanski A, Fletcher C, Maddahi J, Reisman S, Murphy F, Swan HJC:  Localization of left anterior coronary artery disease with exercise equilibrium radionuclide ventriculography.  Clin Nucl Med 7(9S):  p 35, 1982.
  7. Kimchi A, Rozanski A, Fletcher C, Maddahi J, Murphy F, Reisman S, Swan HJC, Berman D:  The relationship between the time of onset of left ventricular wall motion abnormality during exercise and the presence and severity of coronary artery disease.  Clin Nucl Med 7(9S):  p 33, 1982.
  8. Morris D, Rozanski A, Berman D, Maddahi J, Kimchi A, Reisman S, Murphy F, Swan HJC: Accurate detection of “high risk” disease in patients post-myocardial infarction by exercise radionuclide ventriculography.  Circulation 66 (4):  p 272, 1982.
  9. Reisman S, Shellock FG, Shah PK, Berman D, Swan HJC: Relationship between early electrocardiographic changes and left ventricular function in acute transmural anterior myocardial infarction.  Clin Res 31(1): 16A, 1983.
  10. Reisman S, Maddahi J, Swan HJC, Berman D: In patients with a strongly positive exercise electrocardiogram does longer exercise duration mean less extensive ischemia?  J Am Coll Cardiol 1(2):  p 649, 1983.
  11. Reisman S, Shah PK, Shellock FG, Berman D, Swan HJC: Right bundle branch block in acute transmural anterior myocardial infarction:  Relationship of prognosis to degree of ventricular dysfunction.  J Nucl Med  24(5): p 68, 1983.
  12. Reisman S, Berman DS, Maddahi H, Waxman A, Swan HJC: The severe stress thallium-201 defect:  An indicator of critical coronary stenosis.  Circulation 68(4): p 140, 1983.
  13. Reisman S, Berman D, Maddahi J, Swan HJC, Waxman A: Grading the severity of stress thallium-201 defects:  Angiographic correlates. J Nucl Med 25(5):  p 86, 1984.
  14. Reisman S, Berman D, Maddahi J, Swan HJC: Exertional hypotension:  Thallium scintigraphic and angiographic correlates.  Circulation 70(4): p 157, 1984.
  15. Reisman S, Berman DS, Maddahi H, Swan HJC:  Silent myocardial ischemia during treadmill exercise:  Thallium scintigraphic and angiographic correlates.  J Am Coll Cardiol 5(2):  p 406, 1985.
  16. Reisman S, Berman DS, Maddahi J, Swan HJC: Silent myocardial ischemia vs. exertional angina:  Equal extent and severity of thallium-201 abnormalities and frequency of left main stenosis.  Clin Res 33(2):  220A, 1985.
  17. Reisman S, Berman DS, Maddahi J, Swan HJC: Silent myocardial ischemia:  Assessment by exercise thallium-201 scintigraphy and coronary arteriography.  J Nucl Med 26(5):  p 41, 1985.
  18. Reisman S, Maddahi J, Rozanski A, Berman DS: Exercise thallium scintigraphy in patients with ischemia and triple-vessel or left-main coronary disease:  Is exertional angina meaningful?  Clin Nucl Med 10 (9S):  p 12, 1985.
  19. Reisman S, Ladenheim M, Staniloff H, Rozanski A, Berman DS: Prognostic implication of silent ischemia in patients undergoing exercise thallium-201 scintigraphy.  Clin Nucl Med 10(9S):  p 12, 1985.
  20. Reisman S, Maddahi J, Van Train K, Bassir R, Berman D: Quantitation of extent and severity of planar thallium-201 exercise perfusion abnormality.  CLin Nucl Med 10(9S):  p 12, 1985.
  21. Maddahi J, Don Michael T, Becerra A, Murphy F, Bateman T, Reisman S, Kreager A, Waxman A, Berman DS: What is the effect of submaximal exercise heart rate on the results on quantitative thallium-201 stress testing? Clin Nucl Med 10(9S): p 11, 1985.
  22. Maddahi J, Don Michael TA, Becerra A, Murphy F, Reisman S, Kreager A, Ishimori T: Effect of submaximal exercise heart rate on the results of quantitative thallium-201 stress testing. Circulation 72(3): p 137, 1985.
  23. Areeda J. Prigent F, Van Train K, Wong C, Reisman S, Rozanski A, O’Byrne GT: Quantitative analysis of thallium-201 redistribution.  Circulation 72(3):  p 138, 1985.
  24. Reisman S, Ladenheim M, Staniloff HM, Rozanski A, Berman DS: Asymptomatic patients with exercise thallium-201 hypoperfusion: Identification of a high-risk subset.  Circulation 72(3): p 445, 1985
  25. Reisman S, Maddahi J, Rozanski A, Berman D:  “Silent” exertional ischemia in patients with high-risk coronary artery disease: JACC 7(2):  4A, 1986.
  26. Reisman S, Rozanski A, Maddahi J, Berman D: Prolonged post-exercise ST segment depression is an indicator of hemodynamically severe and extensive coronary artery disease (CAD).  JACC 7(2):  163A, 1986.
  27. Reisman S, Maddahi J, Van Train K, Berman D: Quantitation of extent, depth and severity of defects in patients undergoing exercise planar thallium-201 scintigraphy.  JACC 7(2): 176A, 1986.
  28. Maddahi J, Don Michael TA, Gurewitz J, Reisman S, Bateman T, Ishimori T, Berman D: Significance of slow myocardial washout rate of T1-201 at submaximal exercise heart rate.  J Nucl Med 27(6):  p 953, 1986.
  29. Reisman S, Maddahi J, Van Train K, Garcia E, Berman D: A computerized method for quantification of extent, depth and severity of defects in patients undergoing exercise planar thallium-201 scintigraphy.  J Nucl Med 27(6):  p 953, 1986.
  30. Reisman S, Ladenheim M, Staniloff HM, Berman DS: Prognostic stratification of asymptomatic patients by exercise T1-201 scintigraphy: Comparison to patients with typical angina. J Nucl Med 27(6):  p 954, 1986.
  31. Reisman S, Maddahi J, Berman D: In patients with high-risk coronary artery disease and T1-201 ischemia, is exertional angina meaningful?  J Nucl Med 27(6): p 998, 1986.
  32. Reisman S, Rozanski A, Maddahi J, Berman D: Thallium scintigraphic and coronary arteriographic correlates of prolonged post-exercise ST segment depression.  J Nucl Med 27(6): p 998, 1986.
  33. Reisman S, Klepser C, Chandramouly B, Konka S, Sacchi T: Silent myocardial ischemia in patients undergoing intravenous dipyridamole thallium-201 scintigraphy. J Nucl Med 28(4): p 580, 1987.
  34. Reisman S, Klepser C, Sacchi T, Konka S: Quantitation of Tl defects in patients undergoing intravenous dipyridamole planar Tl-201 scintigraphy: Identification of severe and extensive coronary artery disease (CAD).  Circulation 76(4) p 158, 1987.
  35. Reisman S, Klepser C, Vaugeois JC, Burgess C, Chandramouly B: Dipyridamole-induced increase in pulmonary thallium uptake: Marker of transient global left ventricular dysfunction in patients unable to exercise.  JACC 11(2): p 214A, 1988.
  36. Reisman S, Klepser C, Vaugeois JC, Sacchi T, Konka S,: ST segment depression during intravenous dipyridamole thallium infusion: Identification of patients with extensive jeopardized myocardium.  J Nucl Med 29(5): p 782, 1988.
  37. Reisman S, Klepser C, Vaugeois JC, Burgess C, Chandramouly B,: Increased pulmonary thallium-201 uptake after intravenous dipyridamole: A marker of transient global left ventricular dysfunction in patients unable to exercise.  J Nucl Med 29(5):   p 953, 1988.
  38. Reisman S, Klepser C, Vaugeois JC, Chandramouly B,: Intravenous dipyridamole thallium imaging in patients 70 years old or greater:  A safe and effective technique in the elderly:  J Nucl Med 29(5):  p 953, 1988.
  39. Reisman S, Klepser C, et al:  Severe and extensive coronary artery disease in the elderly:  Detection by intravenous dipyridamole thallium imaging.  Circulation 78(4): p 333, 1988.
  40. Reisman S, Klepser C, Sacchi T, Konka S: Dipyridamole-induced  ST segment depression:  Identification of extensive jeopardized myocardium.  Circulation 78(4): p 108, 1988.
  41. Reisman S, Goldsmith J, Franco CD, Wengerter KR, Gupta SK, Veith FJ: Combined intravenous dipyridamole thallium-201 and resting radionuclide ventriculography in risk stratification prior to vascular surgery.  J Cardiovasc Surg 32(4): p 3, 1991.

Publications: Book Chapters

  1. Reisman S.: Myocardial perfusion imaging with thallium-201 in the detection and assessment of coronary artery diseases. In: Cardiovascular Nuclear Medicine, (Lyons K.,ed), Appleton Century and Crofts, East Norwalk, Conn. 1988.

Publications: Articles

  1. Reisman S, Berman D, Maddahi J, Swan HJC: The severe stress thallium defect:  An indicator of critical coronary stenosis.   Am Heart J 110:128-134, 1985.
  2. Reisman S: Dipyridamole thallium testing:  An alternative form of stress testing in patients unable to exercise.  Chest (editorial) 88:321-322, 1985.
  3. Reisman S, Maddahi J, Van Train K, Garcia E, Berman D: Quantitation of extent depth and severity of planar thallium defects in patients undergoing exercise thallium-201 scintigraphy.  J Nucl Med 27:  1273-1281, 1986.

Provider Information

  1. NPI: 1699791665
  2. Specialty: Specialist (174400000X)
  3. License: 1406241
  4. PECOS ID: 8820985369
  5. Practicing from: 1977
  6. Accepts Medicare: Yes